Israel Englander Crispr Therapeutics Ag Call Options Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$44.62 - $62.75 $1.47 Million - $2.07 Million
33,000 New
33,000 $1.55 Million
Q1 2024

May 15, 2024
BUY
$60.67 - $89.12 $188,077 - $276,272
3,100 New
3,100 $211,000
Q2 2023

Aug 14, 2023
BUY
$43.47 - $67.77 $891,135 - $1.39 Million
20,500 Added 68.33%
50,500 $2.84 Million
Q1 2023

May 15, 2023
BUY
$41.0 - $56.12 $1.23 Million - $1.68 Million
30,000 New
30,000 $1.36 Million

Others Institutions Holding CRSP

# of Institutions
490
Shares Held
58M
Call Options Held
1.1M
Put Options Held
1.9M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.19B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email